Your shopping cart is currently empty

Ru-TRZ2 is an effective ruthenium-based chemotherapeutic agent that can induce apoptosis and necroptosis. It also exhibits antitumor activity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Ru-TRZ2 is an effective ruthenium-based chemotherapeutic agent that can induce apoptosis and necroptosis. It also exhibits antitumor activity. |
| In vitro | Ru-TRZ2 (72 h) induces necroptosis, with IC50 values of 0.45 µM and 0.24 µM for HCT116 and HT29 cells, respectively. It also triggers mitochondrial depolarization and apoptosis in HT29 cells. |
| In vivo | Ru-TRZ2, administered intravenously at a dosage of 5 mg/kg every two days for a total of 10 injections, demonstrates antitumor activity in HT29 xenograft mice. |
| Formula | C45H43F6N4O7P2RuS2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.